Moderator
Daniel Ng, PharmD, Astellas Pharma, Singapore, Singapore
Speakers
Jing Wu, RPh, PhD, Tianjin University, Beijing, China; Mitch Higashi, PhD, ISPOR, Villanova, PA, United States; Yang Xie, MPH, PhD, IQVIA, Shanghai, China
The Asia-Pacific region, home to more than half of the world’s population, is characterized by rapid economic growth, cultural diversity, and highly heterogeneous healthcare systems. Healthcare policy reforms are reshaping the global healthcare landscape, redefining how innovation is developed, assessed, and delivered to patients. Evolving approaches to pricing, reimbursement, and healthcare funding are influencing investment decisions, market access, and patient access to innovative therapies. This session will examine how these policy reforms are shaping the healthcare ecosystem and explore strategies to ensure that policies supporting access, affordability, and sustainability today continue to foster an environment that supports the innovation needed for tomorrow. Experts from policy, academia, consulting and industry will provide insights into the key opportunities and challenges, practical approaches to strengthening healthcare systems, improving patient access, and medical innovation to improve health outcomes in the region.
Code
04b